Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
4.700
+0.160 (3.52%)
At close: Mar 6, 2026, 4:00 PM EST
4.467
-0.233 (-4.95%)
After-hours: Mar 6, 2026, 7:23 PM EST
Q32 Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Q32 Bio stock have an average target of 14, with a low estimate of 13 and a high estimate of 15. The average target predicts an increase of 197.87% from the current stock price of 4.70.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Q32 Bio stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +176.60% | Feb 25, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +219.15% | Mar 12, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $22 → $3 | Buy → Hold | Downgrades | $22 → $3 | -36.17% | Feb 11, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $20 → $4 | Buy → Hold | Downgrades | $20 → $4 | -14.89% | Feb 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $64 → $22 | Buy | Maintains | $64 → $22 | +368.09% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.86
from -6.58
EPS Next Year
-2.63
from -2.86
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.27 | -1.19 | |
| Avg | -2.86 | -2.63 | |
| Low | -3.28 | -3.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.